100 research outputs found
Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome.
Despite known histological, biological, and clinical differences between lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC), relatively little is known about the spatial differences in their corresponding immune contextures. Our study of over 1000 LUAD and LUSC tumors revealed that computationally derived patterns of tumor-infiltrating lymphocytes (TILs) on H&E images were different between LUAD (N = 421) and LUSC (N = 438), with TIL density being prognostic of overall survival in LUAD and spatial arrangement being more prognostically relevant in LUSC. In addition, the LUAD-specific TIL signature was associated with OS in an external validation set of 100 NSCLC treated with more than six different neoadjuvant chemotherapy regimens, and predictive of response to therapy in the clinical trial CA209-057 (n = 303). In LUAD, the prognostic TIL signature was primarily comprised of CD4+ T and CD8+ T cells, whereas in LUSC, the immune patterns were comprised of CD4+ T, CD8+ T, and CD20+ B cells. In both subtypes, prognostic TIL features were associated with transcriptomics-derived immune scores and biological pathways implicated in immune recognition, response, and evasion. Our results suggest the need for histologic subtype-specific TIL-based models for stratifying survival risk and predicting response to therapy. Our findings suggest that predictive models for response to therapy will need to account for the unique morphologic and molecular immune patterns as a function of histologic subtype of NSCLC
Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8
Neutrophil extracellular traps (NETs) are webs of extracellular nuclear DNA extruded by dying neutrophils infiltrating
tissue. NETs constitute a defence mechanism to entrap and kill fungi and bacteria. Tumours induce the formation of
NETs to the advantage of the malignancy via a variety of mechanisms shown in mouse models. Here, we investigated
the presence of NETs in a variety of human solid tumours and their association with IL-8 (CXCL8) protein expression
and CD8+ T-cell density in the tumour microenvironment. Multiplex immunofluorescence panels were developed to
identify NETs in human cancer tissues by co-staining with the granulocyte marker CD15, the neutrophil marker myeloperoxidase
and citrullinated histone H3 (H3Cit), as well as IL-8 protein and CD8+ T cells. Three ELISA methods to
detect and quantify circulating NETs in serum were optimised and utilised. Whole tumour sections and tissue microarrays
from patients with non-small cell lung cancer (NSCLC; n = 14), bladder cancer (n = 14), melanoma (n = 11),
breast cancer (n = 31), colorectal cancer (n = 20) and mesothelioma (n = 61) were studied. Also, serum samples
collected retrospectively from patients with metastatic melanoma (n = 12) and NSCLC (n = 34) were ELISA assayed
to quantify circulating NETs and IL-8. NETs were detected in six different human cancer types with wide individual
variation in terms of tissue density and distribution. At least in NSCLC, bladder cancer and metastatic melanoma, NET
density positively correlated with IL-8 protein expression and inversely correlated with CD8+ T-cell densities. In a
series of serum samples from melanoma and NSCLC patients, a positive correlation between circulating NETs and
IL-8 was found. In conclusion, NETs are detectable in formalin-fixed human biopsy samples from solid tumours
and in the circulation of cancer patients with a considerable degree of individual variation. NETs show a positive
association with IL-8 and a trend towards a negative association with CD8+ tumour-infiltrating lymphocytes
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small- cell lung cancer
Most patients with advanced non-small-cell lung cancer (NSCLC) fail to derive significant benefit from programmed cell death protein-1 (PD-1) axis blockade, and new biomarkers of response are needed. In this study, we aimed to discover and validate spatially resolved protein markers associated with sensitivity to PD-1 axis inhibition in NSCLC
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.
OBJECTIVES: The interaction between the immune system and tumor cells is an important feature for the prognosis and treatment of cancer. Multiplex immunohistochemistry (mIHC) and multiplex immunofluorescence (mIF) analyses are emerging technologies that can be used to help quantify immune cell subsets, their functional state, and their spatial arrangement within the tumor microenvironment.
METHODS: The Society for Immunotherapy of Cancer (SITC) convened a task force of pathologists and laboratory leaders from academic centers as well as experts from pharmaceutical and diagnostic companies to develop best practice guidelines for the optimization and validation of mIHC/mIF assays across platforms.
RESULTS: Representative outputs and the advantages and disadvantages of mIHC/mIF approaches, such as multiplexed chromogenic IHC, multiplexed immunohistochemical consecutive staining on single slide, mIF (including multispectral approaches), tissue-based mass spectrometry, and digital spatial profiling are discussed.
CONCLUSIONS: mIHC/mIF technologies are becoming standard tools for biomarker studies and are likely to enter routine clinical practice in the near future. Careful assay optimization and validation will help ensure outputs are robust and comparable across laboratories as well as potentially across mIHC/mIF platforms. Quantitative image analysis of mIHC/mIF output and data management considerations will be addressed in a complementary manuscript from this task force
Imaging and monitoring tumour burden
Trabajo presentado en la 18th Aseica International Conference, celebrada en Santiago de Compostela (España) del 16 al 18 de noviembre de 2022
ANALISIS DE CARACTERISTICAS CLINICAS ASOCIADAS A CITOLOGIA CERVICAL POSITIVA PARA ACTINOMICES
Actinomices es una bacteria oportunista gram positiva no formadora de esporas que aparece ocasionalmente en los genitales femeninos. La infección pélvica es infrecuente, de difícil diagnóstico y se ha demostrado asociación con uso de dispositivos intrauterinos. Material y Método: Se analizaron 36 casos entre 1995 y 2002. Se consideraron edad, tipo y subtipo de método anticonceptivo usado, tiempo de uso del mismo y presencia de síntomas. Resultados: La edad media fue 42 años, con 69% entre los 36 y los 47. 92% usuarias de DIU que presentaron un tiempo medio de uso de 11 años, 52% eran usuarias de Lippes y 48% de T de Cobre. Sólo 44% presentaron algún síntomas. Conclusiones: La detección de Actinomices ocurre casi exclusivamente en usuarias de DIU, más frecuentemente en aquellas entre 35 y 47 años y que presentan un tiempo de uso menor a 15 años. La presencia de síntomas, no parece ser un elemento clínico relevante. No se encontraron diferencias entre usuarias de Lippes y T de Cu en este estudi
- …